PEGAVISION CORPORATION Funds and ETFs Pegavision Corporation
Equities
6491
TW0006491004
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 501 TWD | -5.83% |
|
-2.53% | +26.36% |
| 04-30 | Pegavision Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 01-29 | Pegavision Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
ETFs positioned on Pegavision Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 117 M€ | +2.11% | - | |
| 0.00% | 34 M€ | +2.67% | - |
Pegavision Corp is primarily engaged in the manufacture and sale of private brand contact lenses, as well as the original equipment manufacturing (OEM) business. The Company distributes its products within domestic market and to overseas markets.
Calendar
05/05/2024
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
501
TWD
Average target price
518.2
TWD
Spread / Average Target
+3.43%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +26.36% | 1.21B | |
| +11.23% | 98.38B | |
| +9.93% | 39.34B | |
| -4.20% | 18.02B | |
| -16.61% | 2.33B | |
| -10.04% | 1.51B | |
| -34.97% | 755M | |
| -36.42% | 744M | |
| -8.48% | 665M | |
| +26.67% | 509M |
- Stock Market
- Equities
- 6491 Stock
- Funds and ETFs Pegavision Corporation
